As of July 2025 REGENXBIO has a market cap of C$0.58 Billion. This makes REGENXBIO the world's 7403th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | C$0.58 B | 10.75% |
2024 | C$0.52 B | -49.7% |
2023 | C$1.04 B | -21.39% |
2022 | C$1.33 B | -25.25% |
2021 | C$1.78 B | -17.77% |
2020 | C$2.16 B | 9.5% |
2019 | C$1.97 B | -4.1% |
2018 | C$2.06 B | 58.53% |
2017 | C$1.30 B | 97.27% |
2016 | C$0.65 B | 8.92% |
2015 | C$0.60 B |
On Jul 29th, 2025 the market cap of REGENXBIO was reported to be:
Name | Marketcap | Market cap differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | C$1.29 B | 122.01% | ๐บ๐ธ USA |